Skip to main content
Published locations for No survival benefit of adding tosedostat to LDAC vs. LDAC alone in older patients with AML
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
No survival benefit of adding tosedostat to LDAC vs. LDAC alone in older patients with AML
User login
Username
Password
Reset your password
/content/no-survival-benefit-adding-tosedostat-ldac-vs-ldac-alone-older-patients-aml
/hematology-oncology/article/241344/aml/no-survival-benefit-adding-tosedostat-ldac-vs-ldac-alone